| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 1, 2010Company Teams with Physician and Patient Communities to Pass the National Pain Care Policy Act of 2009
MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) commended the U.S. Congress and President for signing H.R. 3590, the Patient Protection and Affordable Care Act legislation...
-
Apr 1, 2010
MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), announced today that it will appeal the $73.5 million jury verdict returned in the U.S. District Court in Delaware deciding...
-
Mar 29, 2010
MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), today announced the settlement of a lawsuit it initiated against AGA Medical Corp. in 2007 for infringement of Medtronic's...
-
Mar 29, 2010InterStim Therapy for Bowel Control Currently Under Review by the U.S. FDA
MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim(R) Therapy...
-
Mar 23, 2010
Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] Medtronic, Inc. (NYSE: MDT) today announced the enrollment...
-
Mar 19, 2010Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment
MINNEAPOLIS, Mar 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
-
Mar 18, 2010
MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
-
Mar 17, 2010Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
-
Mar 17, 2010Advisa DR MRI(TM) SureScan(TM) Represents the Most Advanced Pacing System from Medtronic that Combines MRI Compatibility with Exclusive Pacing Technology
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European...
-
Mar 17, 2010
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug...
-
Mar 16, 2010Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment
MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
-
Mar 15, 2010Late Breaking Clinical Trial at 59th Annual Scientific Session of the American College of Cardiology (ACC) also Showed Shortened Cardiovascular Hospital Stays
MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from the CONNECT trial showing the median time to clinical decision was significantly...
-
Mar 15, 2010Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation
MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
-
Mar 14, 2010Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients
MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
-
Mar 12, 2010Post-Market Evaluation of Breakthrough Medical Device Begins Enrolling Patients; First Implants Occur in Germany
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc. (NYSE: MDT), today announced the start of the...
-
Mar 12, 2010
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
-
Mar 11, 2010
MINNEAPOLIS, Mar 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45...
-
Mar 10, 2010Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation
MEMPHIS, Tenn., Mar 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System. When a patient has a spinal condition...
-
Mar 9, 2010Lecture Published by Annals of Biomedical Engineering
MINNEAPOLIS, Mar 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's...
-
Mar 4, 2010
Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as one of Massachusetts Institute of Technology
-
Mar 3, 2010Corporate Responsibility Magazine lists Medtronic among 2010's 100 Best Corporate Citizens
NEW YORK, Mar 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) was named today to the 11th annual "100 Best Corporate Citizens List" published by Corporate Responsibility magazine (formerly...
-
Mar 2, 2010
MINNEAPOLIS, Mar 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 30th Annual Cowen and Company Health Care Conference on Tuesday, March 9, 2010,...
-
Feb 23, 2010Non-GAAP diluted EPS of $0.77 grew 8%; GAAP diluted EPS of $0.75 grew 21%International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reportedFree cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billionWorldwide ICD revenue growth of 5% on a constant currency basis; 9% as reportedWorldwide CardioVascular revenue growth of 21% on a constant currency basis; 28% as reported
MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010. The company...
-
Feb 23, 2010
MINNEAPOLIS, Feb 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, has been elected a Fellow of the American Institute of Medical and...
-
Feb 19, 2010
REDMOND, Wash., Feb 19, 2010 (BUSINESS WIRE) -- Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today it received notice from the U.S. Food and Drug...